What's Going On With Polyrizon Shares Wednesday?
What's Going On With Polyrizon Shares Wednesday?
Polyrizon Ltd. (NASDAQ:PLRZ) shares are moving higher after the company announced it secured a manufacturing agreement with Eurofins CDMO Amatsiaquitaine.
Polyrizon Ltd.（纳斯达克股票代码：PLRZ）宣布与EurofinsCDMO Amatsiaquitaine签订了制造协议后，该公司股价走高。
The Details: Under the agreement, Eurofins will supply Polyrizon with Clinical Trial Material (CTM) for its PL-14 allergy blocker trial.
详情：根据该协议，Eurofins将为Polyrizon的 PL-14 过敏阻滞剂试验提供临床试验材料（CTM）。
The clinical trial, expected to commence in 2025, will evaluate the safety and efficacy of PL-14.
该临床试验预计于 2025 年开始，将评估 PL-14 的安全性和有效性。
Tomer Izraeli, CEO of Polyrizon previously stated that, "We are pleased to have established this partnership with Eurofins CDMO Amatsiaquitaine S.A.S, which strengthens our preparation efforts for the upcoming PL-14 clinical trial. We believe that this collaboration marks a significant milestone in our journey toward providing effective allergy protection solutions to patients."
Polyrizon首席执行官托默·以色列此前曾表示：“我们很高兴与Eurofins CDMO Amatsiaquitaine S.A.S建立了这种合作伙伴关系，这加强了我们为即将到来的 PL-14 临床试验的准备工作。我们相信，这种合作标志着我们向患者提供有效的过敏保护解决方案的旅程中的一个重要里程碑。”
Polyrizon stock is trading on higher-than-normal volume at 72.09 million. The company's average session volume over the past 100 days is about 556.58 thousand.
Polyrizon股票的交易量高于正常水平，为7209万。该公司在过去100天中的平均会话量约为55.658万。
PLRZ Price Action: At the time of writing, Polyrizon stock is trading 240.9% higher at $3.55, according to data from Benzinga Pro.
PLRZ价格走势：根据Benzinga Pro的数据，在撰写本文时，Polyrizon股票的交易价格上涨240.9％，至3.55美元。
Image: Michal Jarmoluk from Pixabay
图片：来自 Pixabay 的 Michal Jarmoluk